MHC-Matched Graft-vs-Host Disease Requires Recipient Intestinal Barrier Loss and Natural Killer Cell Inactivation

Get Permission

Although available data indicate an association among pretransplantation conditioning intensity, intestinal barrier loss, and severity of graft-vs-host disease, the multiple effects of irradiation and other types of conditioning have made it difficult to precisely identify the role of intestinal barrier loss in graft-vs-host disease.

In a study reported in Science Translational Medicine, Nalle and colleagues developed graft-vs-host disease models that permitted identification of individual pretransplantation variables. It was found that intestinal damage was required for development of MHC minor-mismatch graft-vs-host disease but not for major-mismatch graft-vs-host disease. Natural killer cells in the transplant recipient were found to prevent minor-mismatch graft-vs-host disease via a perforin-dependent process that limited the expansion of alloreactive T cells and their infiltration into the target organ.

Myeloid differentiation primary response protein 88 (MyD88)-mediated Toll-like receptor 4 signaling on donor cells was required for minor-mismatch graft-vs-host disease. Intestinal damage could be bypassed by parenteral lipopolysaccharide administration, indicating that the influx of bacterial components associated with intestinal barrier loss is a central component in minor-mismatch graft-vs-host disease pathogenesis.

The authors concluded, “In all, the data demonstrate that pretransplant conditioning plays a dual role in promoting minor mismatch [graft-vs-host disease] by both depleting recipient [natural killer] cells and inducing intestinal barrier loss.” ■

Nalle SC, et al: Sci Transl Med 6:243ra87, 2014. 




By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.